The Circadian Rhythm of Copeptin

Circadian Rhythm Clinical Trial

— Co-Rhythm  

Official title:

The Circadian Rhythm of Copeptin

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02604875
• Other study ID #: EKNZ 2015-266
• Status: Completed
• Phase: N/A
• First received: November 10, 2015
• Last updated: August 12, 2016
• Start date: November 2015
• Est. completion date: April 2016

Study information

• Verified date: August 2016
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

The circadian rhythm of copeptin will be examined in healthy subjects.

Description:

In 18 healthy volunteers the circadian rhythm of copeptin will be examined by withdrawing blood samples for copeptin levels every 30 minutes for 24 hours.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• healthy subjects

Exclusion Criteria:

• acute illness

• chronic illness

• pregnancy

• Anemia defined as Hb < 30g/l

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Circadian Rhythm
• Copeptin Blood Levels

Intervention

Other:
• observation
blood sampling during 24 hours

Locations

Country	Name	City	State
Switzerland	University Hospital Basel	Basel	Basel-Stadt

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	measurement of copeptin values in mmol/l within 24 hours to assess the amount of release in a day curve.	The primary outcome measure is to compare the copeptin concentration in the early afternoon and the early morning by blood sampling at different time points. Evaluation of the question if there is a circadian rhythm in the copeptin release.	24 hours	No